Paula Anahi Arias-Loza
Overview
Explore the profile of Paula Anahi Arias-Loza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gram M, Gensler D, Winter P, Seethaler M, Arias-Loza P, Oberberger J, et al.
MAGMA
. 2021 Sep;
35(2):325-340.
PMID: 34491466
Purpose: T dispersion quantification can potentially be used as a cardiac magnetic resonance index for sensitive detection of myocardial fibrosis without the need of contrast agents. However, dispersion quantification is...
2.
Seidlmayer L, Mages C, Berbner A, Eder-Negrin P, Arias-Loza P, Kaspar M, et al.
Front Physiol
. 2019 Aug;
10:733.
PMID: 31379586
Endothelin-1 (ET-1) and angiotensin II (Ang II) are multifunctional peptide hormones that regulate the function of the cardiovascular and renal systems. Both hormones increase the intracellular production of inositol-1,4,5-trisphosphate (IP)...
3.
Williams T, Hundertmark M, Nordbeck P, Voll S, Arias-Loza P, Oppelt D, et al.
Circ Cardiovasc Genet
. 2015 Oct;
8(6):752-64.
PMID: 26499333
Background: E193, a heterozygous truncating mutation in the human transcription cofactor Eyes absent 4 (Eya4), causes hearing impairment followed by dilative cardiomyopathy. Methods And Results: In this study, we first...
4.
Arias-Loza P, Hu K, Frantz S, Dienesch C, Bayer B, Wu R, et al.
Toxicol Pathol
. 2011 Jun;
39(5):867-78.
PMID: 21670166
The role of estrogens during myocardial ischemia has been extensively studied. However, effects of a standard hormone replacement therapy including 17β-estradiol (E2) combined with medroxyprogesterone acetate (MPA) have not been...
5.
Arias-Loza P, Jazbutyte V, Pelzer T
Gend Med
. 2008 May;
5 Suppl A:S34-45.
PMID: 18395682
Background: The biological functions of estrogens extend beyond the female and male reproductive tract, affecting the cardiovascular and renal systems. Traditional views on the role of postmenopausal hormone therapy (HT)...
6.
Jazbutyte V, Arias-Loza P, Hu K, Widder J, Govindaraj V, von Poser-Klein C, et al.
Cardiovasc Res
. 2007 Dec;
77(4):774-81.
PMID: 18056768
Aims: The biological effects of oestrogens are mediated by two different oestrogen receptor (ER) subtypes, ERalpha and ERbeta, which might play different, redundant, or opposing roles in cardiovascular disease. Previously,...
7.
Arias-Loza P, Hu K, Schafer A, Bauersachs J, Quaschning T, Galle J, et al.
Hypertension
. 2006 Sep;
48(5):994-1001.
PMID: 17000933
Controversial results obtained from human and animal studies on the prevention of heart disease by estrogens and progestins warrant a better understanding of nuclear hormone receptor function and interaction. To...
8.
Pelzer T, Jazbutyte V, Arias-Loza P, Segerer S, Lichtenwald M, Law M, et al.
Biochem Biophys Res Commun
. 2005 Mar;
329(2):726-32.
PMID: 15737646
Peroxisome proliferator-activated receptor-gamma (PPARgamma) plays a critical role in peripheral glucose homeostasis and energy metabolism, and inhibits cardiac hypertrophy in non-diabetic animal models. The functional role of PPARgamma in the...